Clinical trial
Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
NCT06447532
Study timeline
Study start (actual)2024-08-01Date precision: day
Registry last updated2025-03-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Sponsors & collaborators
Federal University of São Paulolead sponsor
Kansai Medical Universitycollaborator
University of Sao Paulocollaborator
Kyoto Universitycollaborator
Barretos Cancer Hospitalcollaborator
Women's College Hospitalcollaborator
Emory Universitycollaborator
University of Campinas, Brazilcollaborator
Instituto Nacional de Cancer, Brazilcollaborator
Universidade Federal do Triangulo Mineirocollaborator
Hospital Vall d'Hebroncollaborator
Mansoura Universitycollaborator
Seoul National Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06447532 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.